Camp4 Therapeutics (CAMP) Amortizatization of Intangibles (2024 - 2026)
Camp4 Therapeutics recorded quarterly Amortizatization of Intangibles of $34000.0 in Q1 2026, down 92.92% quarter-over-quarter from $480000.0 in Q4 2025, and down 92.84% year-over-year from $475000.0 in Q1 2025.
Camp4 Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $34000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 92.84% year-over-year to $34000.0; the TTM figure through Mar 2026 stood at $1.5 million (down 18.62% YoY), while the FY2025 annual figure was $1.9 million, up 9.95% from the prior year.
- Amortizatization of Intangibles came in at $34000.0 for Q1 2026 at Camp4 Therapeutics, down from $480000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $489000.0 in Q3 2025 to a low of $34000.0 in Q1 2026.
- A 3-year average of $411777.8 and a median of $464000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles advanced 17.87% in 2025 and tumbled 92.84% in 2026, its largest moves.
- Camp4 Therapeutics' Amortizatization of Intangibles stood at $464000.0 in 2024, then climbed by 3.45% to $480000.0 in 2025, then sank by 92.92% to $34000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $34000.0, $480000.0, and $489000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Mar 31, 2024 | 403,000.00 |